RxDoctor Payments Data

Ronny Antelo

Neurology · Fairless Hills, PANPI 1508895483

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,282 of the $2,792 with a category attached, or 81.7%. 22 manufacturers reported payments, led by Teva Pharmaceuticals USA, Inc. at 25.7% of the total. Reporting peaked in 2021 at $1,638 and has fallen 94.6% since, to $88 in 2022.

$2,792in general payments, 2019–2025

Across 107 payments — averaging $26.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$716
  • UCB, Inc.$283
  • Sanofi$280
  • Biogen$246
  • CSL Behring$210
  • AstraZeneca$210
  • plus $848 from 16 others

What the payments were for

  • Consulting fees$1505%
  • Speaking & faculty fees$2609%
  • Food & beverage$2,28282%
  • Education$1004%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,792 in reported general payments places this provider in the 65th percentile of 941 neurology providers in Pennsylvania.

See all neurology providers in Pennsylvania →

Other neurology in Fairless Hills

See the full list for Pennsylvania →

Where these figures come from

Is this you, or does something look wrong? →